Medical and Pharmaceutical Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe Joseph MortonMarch 10, 2025
Medical and Pharmaceutical TG Therapeutics stock spikes on strong financials and optimism for its flagship drug The company's product for relapsing forms of multiple sclerosis (RMS), is its primary source of its most recent success Joseph MortonMarch 3, 2025
Medical and Pharmaceutical New drug could open personalized treatment strategies for prostate cancer Screening men for BCL2 could allow for the development of personalized treatment plans Joseph MortonSeptember 17, 2024